Colinz Labs

{
  "main_header": {
    "sid": 621096,
    "name": "Colinz Labs",
    "stock_name": "Colinz Labs",
    "full_name": "Colinz Laboratories Ltd",
    "name_url": "stocks-analysis/colinz-labs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "82.00",
    "chg": 2.05,
    "chgp": "2.56%",
    "dir": 1,
    "prev_price": "79.95",
    "mcapval": "21.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531210,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE923C01011",
    "curr_date": "Jul 21, 03:30 PM",
    "curr_time": "03:23 AM",
    "last_traded_at": "Jul 21, 03:30 PM IST",
    "bse_nse_vol": "1.91 k",
    "exc_status": "Active",
    "traded_date": "Jul 21, 2026",
    "traded_date_str": "2026 07 21",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/colinz-labs-621096-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "When is the next results date for Colinz Laboratories Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-colinz-laboratories-ltd-4114142",
        "imagepath": "",
        "date": "2026-07-21 23:16:49",
        "description": "The next results date for Colinz Laboratories Ltd is scheduled for 30 July 2026...."
      },
      {
        "title": "Colinz Laboratories Ltd Valuation Shifts Signal Caution Amid Strong Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/colinz-laboratories-ltd-valuation-shifts-signal-caution-amid-strong-returns-4102920",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ColinzLaborator_valuationdot_4102920.png",
        "date": "2026-07-15 08:00:42",
        "description": "Colinz Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters shift notably, moving from fair to expensive territory. This change, coupled with a recent downgrade in its Mojo Grade from Hold to Sell, raises important questions about the stock’s price attractiveness amid a backdrop of strong returns relative to the Sensex."
      },
      {
        "title": "Colinz Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/colinz-laboratories-ltd-valuation-shifts-signal-renewed-price-attractiveness-4092684",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ColinzLaborator_valuationdot_4092684.png",
        "date": "2026-07-08 08:00:37",
        "description": "Colinz Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently undergone a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. This change, coupled with its robust multi-year returns outperforming the Sensex, invites a closer examination of its price attractiveness relative to historical levels and peer benchmarks."
      },
      {
        "title": "Colinz Laboratories Ltd Valuation Shifts Signal Price Attractiveness Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/colinz-laboratories-ltd-valuation-shifts-signal-price-attractiveness-challenges-4076276",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ColinzLaborator_valuationdot_4076276.png",
        "date": "2026-06-29 08:00:45",
        "description": "Colinz Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, prompting a downgrade in its investment grade from Hold to Sell. With its price-to-earnings (P/E) ratio rising to 37.32 and price-to-book value (P/BV) at 1.93, the stock now trades in the 'expensive' category, raising questions about its price attractiveness relative to historical and peer benchmarks."
      },
      {
        "title": "Colinz Laboratories Surges 21.50% Amid Valuation Shift and Mixed Fundamentals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/colinz-laboratories-surges-2150-amid-valuation-shift-and-mixed-fundamentals-4075486",
        "imagepath": "",
        "date": "2026-06-27 16:05:41",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>22 Jun:</strong> Downgrade to Sell announced amid valuation and financial concerns</p>\n                    <p><strong>22 Jun:</strong> Valuation grade shifts from attractive to fair despite strong returns</p>\n                    <p><strong>25 Jun:</strong> Stock closes at Rs.75.55, marking a 21.50% weekly gain</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.62.18</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.75.55</div><div class=\"stat-change positive\">+21.50%</div></div>\n       ..."
      },
      {
        "title": "Colinz Laboratories Ltd Downgraded to Sell Amid Valuation and Financial Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/colinz-laboratories-ltd-downgraded-to-sell-amid-valuation-and-financial-concerns-4066699",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ColinzLaborator_mojoScore_4066699.png",
        "date": "2026-06-22 08:03:21",
        "description": "Colinz Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 19 June 2026. The downgrade reflects a reassessment across four critical parameters: quality, valuation, financial trend, and technicals, with valuation concerns and flat recent financial performance driving the change despite the stock’s strong market-beating returns over the past year."
      },
      {
        "title": "Colinz Laboratories Ltd Valuation Shifts Amid Strong Market Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/colinz-laboratories-ltd-valuation-shifts-amid-strong-market-returns-4066517",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ColinzLaborator_valuationdot_4066517.png",
        "date": "2026-06-22 08:00:49",
        "description": "Colinz Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade. This change, coupled with a recent downgrade in its Mojo Grade from Hold to Sell, signals a recalibration of investor sentiment despite the company’s strong stock performance relative to the Sensex over multiple time horizons."
      },
      {
        "title": "Colinz Laboratories Ltd Gains 15.30%: Technical Upgrades Amidst Flat Fundamentals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/colinz-laboratories-ltd-gains-1530-technical-upgrades-amidst-flat-fundamentals-4052386",
        "imagepath": "",
        "date": "2026-06-13 17:22:20",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>1 June:</strong> Upgrade to Sell rating on technical improvements despite weak fundamentals</p>\n                    <p><strong>2 June:</strong> Further upgrade to Hold as technicals strengthen amid flat financials</p>\n                    <p><strong>3 June:</strong> Downgrade back to Sell amid mixed technical signals and fair valuation</p>\n                    <p><strong>4 June:</strong> Valuation shifts signal changing market sentiment</p>\n                    <p><strong>5 June:</strong> Week closes at Rs.61.65, up 15.30% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div>..."
      },
      {
        "title": "Colinz Laboratories Declines 11.31% Amid Valuation Upgrade and Mixed Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/colinz-laboratories-declines-1131-amid-valuation-upgrade-and-mixed-market-sentiment-4051384",
        "imagepath": "",
        "date": "2026-06-13 13:01:19",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>8 Jun:</strong> Stock opens at Rs.61.90, marginal gain amid Sensex decline</p>\n                    <p><strong>9 Jun:</strong> Rating upgraded to Hold on attractive valuation</p>\n                    <p><strong>10 Jun:</strong> Valuation metrics signal renewed price appeal</p>\n                    <p><strong>12 Jun:</strong> Stock recovers slightly to close at Rs.54.68</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.61.65</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.54.68</div><div..."
      }
    ],
    "total": 621,
    "sid": "621096",
    "stock_news_url": "https://www.marketsmojo.com/news/colinz-laboratories-621096"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Notice Of Date Of Board Meeting Pursuant To Regulation 29(2) Of SEBI (LODR) Regulations 2015.",
      "datetime": "18-Jul-2026",
      "details": "Colinz Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 inter alia to consider and approve This is to inform the exchange that the meeting of the Board of Directors of the Company pursuant to Regulation 29(2) & 33 of SEBI (LODR) Regulations 2015 is scheduled to be held on Thursday 30th July 2026 at the registered office of the Company at A-101 Pratik Industrial Estate Mulund Link Road Mumbai Maharashtra 400078 at 3.30 p.m. inter-alia The detailed ponits aare attached to this letter kindly take the same on records. For Colinz Labs Ltd Director",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "14-Jul-2026",
      "details": "Dear Sir As required under under SEBI Regulation 2015 Please find the attached intimation towards closure of Trading form 1-7-2026 till the 48 hours of the Issue of Quarterly results as on 30-6-2026. Kindly take the same on records. For Colinz Labs Ltd Director",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Jul-2026",
      "details": "Dear Sir Please find the attached Certificate issued by our RTA Bigshare Services Pvt Ltd. for the Quarter ended on 30-6-2026 as required under regulation 74(5). Kindly tahe the same o records. for Colinz Labs Ltd Director",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "30 Jul 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

When is the next results date for Colinz Laboratories Ltd?

2026-07-21 23:16:49

The next results date for Colinz Laboratories Ltd is scheduled for 30 July 2026....

Read full news article

Colinz Laboratories Ltd Valuation Shifts Signal Caution Amid Strong Returns

2026-07-15 08:00:42

Colinz Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters shift notably, moving from fair to expensive territory. This change, coupled with a recent downgrade in its Mojo Grade from Hold to Sell, raises important questions about the stock’s price attractiveness amid a backdrop of strong returns relative to the Sensex.

Read full news article

Colinz Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-07-08 08:00:37

Colinz Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently undergone a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. This change, coupled with its robust multi-year returns outperforming the Sensex, invites a closer examination of its price attractiveness relative to historical levels and peer benchmarks.

Read full news article

Colinz Laboratories Ltd Valuation Shifts Signal Price Attractiveness Challenges

2026-06-29 08:00:45

Colinz Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, prompting a downgrade in its investment grade from Hold to Sell. With its price-to-earnings (P/E) ratio rising to 37.32 and price-to-book value (P/BV) at 1.93, the stock now trades in the 'expensive' category, raising questions about its price attractiveness relative to historical and peer benchmarks.

Read full news article

Colinz Laboratories Surges 21.50% Amid Valuation Shift and Mixed Fundamentals

2026-06-27 16:05:41

Key Events This Week

22 Jun: Downgrade to Sell announced amid valuation and financial concerns

22 Jun: Valuation grade shifts from attractive to fair despite strong returns

25 Jun: Stock closes at Rs.75.55, marking a 21.50% weekly gain

Week Open

Rs.62.18

Week Close

Rs.75.55

+21.50%

...

Read full news article

Colinz Laboratories Ltd Downgraded to Sell Amid Valuation and Financial Concerns

2026-06-22 08:03:21

Colinz Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 19 June 2026. The downgrade reflects a reassessment across four critical parameters: quality, valuation, financial trend, and technicals, with valuation concerns and flat recent financial performance driving the change despite the stock’s strong market-beating returns over the past year.

Read full news article

Colinz Laboratories Ltd Valuation Shifts Amid Strong Market Returns

2026-06-22 08:00:49

Colinz Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade. This change, coupled with a recent downgrade in its Mojo Grade from Hold to Sell, signals a recalibration of investor sentiment despite the company’s strong stock performance relative to the Sensex over multiple time horizons.

Read full news article

Colinz Laboratories Ltd Gains 15.30%: Technical Upgrades Amidst Flat Fundamentals

2026-06-13 17:22:20

Key Events This Week

1 June: Upgrade to Sell rating on technical improvements despite weak fundamentals

2 June: Further upgrade to Hold as technicals strengthen amid flat financials

3 June: Downgrade back to Sell amid mixed technical signals and fair valuation

4 June: Valuation shifts signal changing market sentiment

5 June: Week closes at Rs.61.65, up 15.30% for the week

Week Open

...

Read full news article

Colinz Laboratories Declines 11.31% Amid Valuation Upgrade and Mixed Market Sentiment

2026-06-13 13:01:19

Key Events This Week

8 Jun: Stock opens at Rs.61.90, marginal gain amid Sensex decline

9 Jun: Rating upgraded to Hold on attractive valuation

10 Jun: Valuation metrics signal renewed price appeal

12 Jun: Stock recovers slightly to close at Rs.54.68

Week Open

Rs.61.65

Week Close

Rs.54.68

Read full news article

View All News